Skip to main content
SpringerLink
Log in

Increased Folate Intake with No Changes in Serum Homocysteine and Decreased Levels of C-Reactive Protein in Patients with Inflammatory Bowel Diseases

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In order to increase dietary folic acid intake and to improve nutritional status regarding folate by controlling homocysteine concentrations, ten patients with inflammatory bowel diseases (Crohn’s disease in the colon and ulcerative colitis) received individualized nutritional guidance and were followed up as outpatients for 2 months. The following procedures were performed at the beginning of the study (T0), after 1 month (T1) and at the end of the study (T2): collection of anthropometric data (weight and height), dietary data (24 h diet recall), and blood under fasting condition for the determination of serum folic acid, homocysteine, C-reactive protein, and vitamin B12. Plasma folic acid deficiency was not detected but hyperhomocysteinemia was present in six individuals and C-reactive protein (CRP) was increased (>0.5 mg/dl) in seven patients. After the patients were instructed there was a significant increase in vitamin B6 intake (about 35%) and in folate intake (49.6%). Mean plasma levels of folic acid, homocysteine, and vitamin B12 did not change, but there was a significant decrease of CRP at T1, 0.36 mg dl−1 on average (P = 0.01), which was maintained at T2. We conclude that the increased folate intake reported by this group of patients was not reflected in improved serum concentrations of folic acid and homocysteine. However, the guidelines for the patients probably induced them to choose a more adequate diet, providing nutrients that help control the inflammatory process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kim YI, Fawaz K, Knox T, Lee YM, Norton R, Arora S et al (1998) Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps. Am J Clin Nutr 68:866–872

    PubMed  CAS  Google Scholar 

  2. Stern JM, Saver JL, Boldy RM, DeGregorio F (1998) Homocysteine associated hypercoagulability and disseminated thrombosis—a case report. Angiology 49:765–769

    Article  PubMed  CAS  Google Scholar 

  3. Cattaneo M, Vecchi M, Zighetti ML, Saibeni S, Martinelli I, Omodei P et al (1998) High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 80:542–545

    PubMed  CAS  Google Scholar 

  4. Koutroubakis IE, Dilaveraki E, Vlachonikolis IG, Vardas E, Vrentzos G, Ganotakis E et al (2000) Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig Dis Sci 45:2347–2351. doi:10.1023/A:1005583606647

    Article  PubMed  CAS  Google Scholar 

  5. Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I et al (2001) Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 96:2677–2682. doi:10.1111/j.1572-0241.2001.04127.x

    Article  PubMed  CAS  Google Scholar 

  6. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE et al (1998) Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338:1009–1015. doi:10.1056/NEJM199804093381501

    Article  PubMed  CAS  Google Scholar 

  7. Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S (2000) Increased levels of homocysteine in patients with Crohn’s disease are related to folate levels. Am J Gastroenterol 95:3498–3502. doi:10.1111/j.1572-0241.2000.03367.x

    Article  PubMed  CAS  Google Scholar 

  8. Mahmud N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM et al (1999) Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45:389–394

    Article  PubMed  CAS  Google Scholar 

  9. Oldenburg B, Fijnheer R, van der Griend R, vanBerge-Henegouwen GP, Koningsberger JC (2000) Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 95:2825–2830. doi:10.1111/j.1572-0241.2000.03193.x

    Article  PubMed  CAS  Google Scholar 

  10. Rock CL, Moskowitz A, Huizar B, Saenz CC, Clark JT, Daly TL et al (2001) High vegetable and fruit diet intervention in premenopausal women with cervical intraepithelial neoplasia. J Am Diet Assoc 101:1167–1174. doi:10.1016/S0002-8223(01)00286-3

    Article  PubMed  CAS  Google Scholar 

  11. Rosman-Urbach M, Niv Y, Birk Y, Morgenstern S, Schwartz B (2006) Relationship between nutritional habits adopted by ulcerative colitis relevant to cancer development patients at clinical remission stages and molecular-genetic parameters. Br J Nutr 95:188–195. doi:10.1079/BJN20051624

    Article  PubMed  CAS  Google Scholar 

  12. Nanri A, Yoshida D, Yamaji T, Mizoue T, Takayanagi R, Kono S (2008) Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr 87(5):1488–1496

    PubMed  CAS  Google Scholar 

  13. Valtueña S, Pellegrini N, Franzini L, Bianchi MA, Ardigò D, Del Rio D et al (2008) Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 87(5):1290–1297

    PubMed  Google Scholar 

  14. Rodgers AD, Cummins AG (2007) CRP correlates with clinical score in ulcerative colitis but not in Crohn’s disease. Dig Dis Sci 52:2063–2068. doi:10.1007/s10620-006-9691-2

    Article  PubMed  Google Scholar 

  15. IOM (2000) Dietary reference intakes: applications in dietary assessment. National Academic, Washington, DC

    Google Scholar 

  16. Murolo AC, Silva EM, Silva EM, Gonçalves V (1999) Tables de Estatística, 2nd edn. Revinter

  17. Schall R (1991) Estimation in generalized linear models with random effects. Biometrika 78:719–727. doi:10.1093/biomet/78.4.719

    Article  Google Scholar 

  18. Littell RC, Milliken GA, Sroup WW, Wolfinger RD (1996) SAS system for mixed models. SAS Institute, Cary, NC

    Google Scholar 

  19. Zvirbliene A, Kiudelis G, Zalinkevicius R, Kupcinskas L (2006) Dietary characteristics of patients with inflammatory bowel disease. Medicina (Kaunas) 42:895–899

    Google Scholar 

  20. Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N (2005) Hyperhomocysteinemia in ulcerative colitis is related to folate levels. World J Gastroenterol 11:6038–6042

    PubMed  CAS  Google Scholar 

  21. Drzewosk J, Gasiorowska A, Maecka-Panas E, Bald E, Czupryniak L (2006) Plasma total homocysteine in the active stage of ulcerative colitis. J Gastroenterol Hepatol 21:739–743. doi:10.1111/j.1440-1746.2006.04255.x

    Article  CAS  Google Scholar 

  22. Roblin X, Germain E, Phelip JM, Ducros V, Pofelski J, Heluwaert F et al (2006) Factors associated with hyperhomocysteinemia in inflammatory bowel disease: prospective study in 81 patients. Rev Med Interne 27:106–110. doi:10.1016/j.revmed.2005.11.005

    PubMed  CAS  Google Scholar 

  23. Romagnuolo J, Fedorak RN, Dias VC, Bamforth F, Teltscher M (2001) Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol 96:2143–2149. doi:10.1111/j.1572-0241.2001.03950.x

    Article  PubMed  CAS  Google Scholar 

  24. Mahmood A, Needham J, Prosser J, Mainwaring J, Trebble T, Mahy G et al (2005) Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 17:739–744. doi:10.1097/00042737-200507000-00008

    Article  PubMed  CAS  Google Scholar 

  25. Garofolo L, Barros N Jr, Miranda F Jr, D’Almeida V, Cardien LC, Ferreira SR (2007) Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population. Eur J Vasc Endovasc Surg 34(1):23–28. doi:10.1016/j.ejvs.2007.02.008

    Article  PubMed  CAS  Google Scholar 

  26. Tavares EF, Vieira-Filho JP, Andriolo A, Perez AB, Vergani N, Sañudo A et al (2004) Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors. Ethn Dis 14(1):49–56

    PubMed  Google Scholar 

  27. Helfenstein T, Fonseca FA, Relvas WG, Santos AO, Dabela ML, Matheus SC et al (2005) Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta 355(1–2):165–172. doi:10.1016/j.cccn.2004.12.002

    Article  PubMed  CAS  Google Scholar 

  28. Chamouard P, Richert Z, Meyer N, Rahmi G, Baumann R (2006) Diagnosed value of C-reactive protein for predicting activity level of Crohn’s disease. Clin Gastroenterol Hepatol 4:882–887. doi:10.1016/j.cgh.2006.02.003

    Article  PubMed  CAS  Google Scholar 

  29. Filik L, Dagli U, Ulker A (2006) C-reactive protein and monitoring the activity of Crohn’s disease. Adv Ther 23:655–662. doi:10.1007/BF02850054

    Article  PubMed  CAS  Google Scholar 

  30. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431. doi:10.1136/gut.2005.069476

    Article  PubMed  CAS  Google Scholar 

  31. Zilberman L, Maharshak N, Arbel Y, Rogowski O, Rozenblat M, Shapira I et al (2006) Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn’s disease and ulcerative colitis. Digestion 73:205–209. doi:10.1159/000094531

    Article  PubMed  CAS  Google Scholar 

  32. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11:707–712. doi:10.1097/01.MIB.0000173271.18319.53

    Article  PubMed  Google Scholar 

  33. Vermeire S, Van Assche G, Rutgeerts P (2004) C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10:661–665. doi:10.1097/00054725-200409000-00026

    Article  PubMed  Google Scholar 

  34. Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425–432

    PubMed  CAS  Google Scholar 

  35. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511. doi:10.1161/01.CIR.0000052939.59093.45

    Article  PubMed  Google Scholar 

  36. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84(6):1489–1497

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine of Ribeirão Preto, USP, Av Bandeirantes, 3900, Ribeirao Preto, SP, 14049-190, Brazil

    P. G. Chiarello, F. R. O. Penaforte, C. C. Japur, C. D. A. S. Souza, H. Vannucchi & L. E. A. Troncon

Authors
  1. P. G. Chiarello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. R. O. Penaforte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. C. Japur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. D. A. S. Souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Vannucchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. E. A. Troncon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. G. Chiarello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiarello, P.G., Penaforte, F.R.O., Japur, C.C. et al. Increased Folate Intake with No Changes in Serum Homocysteine and Decreased Levels of C-Reactive Protein in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 54, 627–633 (2009). https://doi.org/10.1007/s10620-008-0398-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0398-4

Keywords

Search

Navigation